Last reviewed · How we verify
NCT07374367
Isthmin-1 as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings
trial in Disease Activity in 66 participants. Not yet recruiting.
1 September 2027
Quick facts
| Lead sponsor | Amera Imam Abdel - Ghany Ahmed |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 66 |
| Start date | 1 May 2026 |
| Primary completion | 1 September 2027 |
| Estimated completion | 1 December 2027 |
Conditions studied
- Disease Activity — all drugs for Disease Activity →
Sponsor
Amera Imam Abdel - Ghany Ahmed
Who can join
Adults 18 to 65, any sex, with Disease Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this case control study is to detect serum isthmin-1 level in RA patient compered to healthy control . The main questions it aims to answer are: what is the serum isthmin-1 level in RA patient? what is the correlation between serum isthmin-1 and RA disease activity? what is the correlation between serum isthmin-1 level and MSUS finding in RA patients?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07374367
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Disease Activity
Currently open trials in the same condition.
- NCT06945549 — Evaluation of Intestinal Lesions and Disease Activity in Inflammatory Bowel Disease Based on 18F-FAPI PET Imaging · recruiting
- NCT07359326 — The Effect of Cold Application in Patients With Rheumatoid Arthritis · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07374367 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Amera Imam Abdel - Ghany Ahmed
- Last refreshed: 28 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07374367.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing